Correlation of Serum Anti-Müllerian Hormone (AMH) Levels on Identification of Premenopausal Patients (pts) with Hormone Receptor Positive (HR+), HER2-negative, Node-Positive Breast Cancer Most Likely to Benefit from Adjuvant Chemotherapy in SWOG S1007 (Rxponder).